Recently, Hunan Provincial Department of Science and Technology released the "2020 Hunan Provincial Clinical Medicine Research Center and Clinical Medical Technology Demonstration Base List", in which declares the application of Xiangtan Central Hospital for "Hunan Provincial Clinic Medical Technology Demonstration Base for Stroke Emergency" was successfully approved.
|
The stroke center of our hospital was established in 2015. In the past 5 years of practice and exploration, the center has broken the barriers of disciplines and included the stroke treatment to the emergency system, realizing one-stop management of stroke treatment. It creates a pioneering first aid “Xiangtan Mode” for stroke with six features: standardized language, path-based management, thrombolysis in the CT room, thrombolysis in the ambulance, zero pause in the emergency room, and zero wait in the catheter lab, which shortens the DNT and DPT to 25 minutes and 50 minutes respectively. So far, 1,223 patients have been successfully treated with thrombolytic therapy. In 2020, 148 cases of emergency thrombectomy have been carried out. The above indicators are at the leading level in both province-wide and nationwide.
In November 2020, the stroke center was awarded the "Advanced Stroke Center" by the Stroke Prevention and Treatment Project of the National Health Commission, ranking 59th in comprehensive strength, 21st in intravenous thrombolysis and 12nd in EVT among nearly 500 advanced stroke centers nationwide.
After the Demonstration Base is approved for establishment, it will give full play to its advantages in the field of stroke first aid, and actively cultivate compound stroke first aid talent for medical institutions at all levels, improve their stroke treatment capabilities, and strive to control the average DNT time of Hunan within 30 minutes as soon as possible.
In the afternoon of January 22nd, Xiangtan Central Hospital started its fifth video meeting with MATAT. On the meeting, MATAT invited Dr. Dabby Dan, a renowned Orthopedic Surgeon and the Head of the Israeli Hip and Knee Society, to introduce the alignment in clinic practices. Tang Xinqiao, the vice president of the hospital, who is also an orthopedics specialist, key members of orthopedics department, and medical students attended the meeting.
For orthopedic surgery such as joint replacement, the effect of "alignment" (that is, the positional relationship between the broken ends of the bones) is a more important part of the whole treatment process. In the video lecture, Dr. Dan elaborated the comparison between mechanical alignment and kinematic alignment and showed some real cases. In the discussion part, Dr. Dan answered several questions on "patella replacement" and "distal femoral osteotomy" in response to audience.
 |
Tang Xinqiao said, “some medical concepts such as‘respect the nature of patients’ put forward by Dr. Dan in the lecture are very innovative and enlightening to us. This lecture has further broadened our horizons. "
In the past few days, the first batch of vaccine injections preventing COVID-19 virus free of charge has been launched in various parts of Hunan. In accordance with the Xiangtan Center for Disease Control and Prevention's vaccination work arrangement, Xiangtan Central Hospital started the vaccine jabs for its employees from January 6.
The hospital leaders attached great importance to the injection work. Zeng Jianping, Vice Chairman of the Xiangtan CPPCC and President of the Hospital, and Xia Hong, Secretary of the Party Committee of the Hospital, made overall arrangements and meticulous planning to ensure the smooth progress of employee vaccine jabs. At 3:30 in the afternoon on the day, Zeng Jianping came to vaccine injection clinic located on the first floor of Building 3 and was the first person to complete the injection. He took practical actions to encourage employees to actively take the vaccine and establish a healthy barrier to prevent COVID-19.
 |
It is reported that the 500 vaccines allocated by the Hospital this time have all been stored in the warehouse and are supplied for 250 medical staff. The vaccine name is SARS-Cov-2 Vaccine, which was approved for marketing on December 31, 2020. Each subject must first make an appointment in the Department of General Medicine, and then go through information verification, informed consent, vaccine jab, observation, etc. to complete the entire vaccination process. As of 5 pm on the day, a total of 37 people completed the first dose of the vaccine, and no adverse reactions were reported.
Here below are some details for your reference if you want to take the vaccine
Question: How many shots of the vaccine?
Answer: The recommended immunization program is 2 injections with at least 14 days between them. The recommended vaccination site is the deltoid muscle of the upper arm. Arbitrary adjustment of immunization program may affect safety, immune response effect and immune durability.
Question: What are the benefits of taking the vaccine?
Answer: Among the high-risk exposure groups who received emergency vaccine in China, more than 60,000 people went to high-risk areas abroad, and the risk and severity of infection of those who were vaccinated were lower than those who had not been vaccinated. It suggests that the vaccine has potential clinical application value.
Question: How long can antibodies last after being vaccinated?
Answer: The virus was discovered in less than a year, so it is too early to draw a conclusion on how long the vaccine can protect us. The latest evidence suggests that according to WHO regulations, the protection period of the vaccine is more than half a year, and there is basically no problem.
Question: What are the possible adverse reactions to the vaccine?
Answer: Symptoms for adverse reactions typically include: headache and fever, local redness, or lumps, and some people have cough, loss of appetite, vomiting, and diarrhea.
Question: What to do if there is an adverse reaction?
Answer: After the vaccine injection is completed, the subject should stay at the vaccine site for 30 minutes before leaving. If symptoms related to adverse reactions occurred after returning home, the subject should report to the medical staff and seek medical attention if necessary.
Question: Who is not suitable for the vaccine?
Answer: Pregnant women, breastfeeding women, people who are in the acute phase of fever, infection and other diseases, and people suffering from immunodeficiency or immune disorders, as well as severe liver and kidney diseases, drug-uncontrollable hypertension, diabetes complications, malignant diseases, and tumor.
People who are not in the 18-59 age range should wait for further clinical trial data disclosure to determine whether they can be vaccinated in the future.
Question: Are SARS-Cov-2 Vaccine and other vaccines co-existable?
Answer: It is not recommended to vaccinate simultaneously with other vaccines.
Question: After receiving the vaccine, do I need to continue to wear masks?
Answer: So far, the protective effect of any vaccine has not reached 100%, and a small number of people may still not able to prevent disease and get infected after vaccination. At present, herd immunity has not been established.
Therefore, after vaccination, personal protective measures such as wearing masks, washing hands frequently, opening windows for ventilation, and maintaining social distance are still required.
Question: Do I still need a nucleic acid test after receiving the vaccine? Can I replace the nucleic acid test report with the vaccination certificate?
Answer: Vaccination can reduce the risk of infection to a certain extent, but the protective effect of any vaccine cannot reach 100%. If necessary, it should still cooperate with relevant departments to carry out nucleic acid testing.
Reservation hotline: 0731-58214922 Emergency center Tel: 0731-58214120
Copyright: Xiangtan Central Hospital
Address: 120 Heping Road, Xiangtan City
